Shanbalaji Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.00 Cr
- Revenue Growth 21.65%
- Profit Growth 52.30%
- Ebitda 55.00%
- Net Worth -5.51%
- Total Assets -81.69%
About Shanbalaji Pharma
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909TG2018PTC169180
- Company No.
121818
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2018
- Date of AGM
16 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Shanbalaji Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Selvakumar Shanmugham  | Managing Director | 01-Oct-2018 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Palepu Gopal | Nominee Director | 29-Oct-2019 | Current |
| Narasaiah Arigela | Nominee Director | 22-Aug-2022 | Current |
Financial Performance of Shanbalaji Pharma.
Shanbalaji Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.65% increase. The company also saw a substantial improvement in profitability, with a 52.3% increase in profit. The company's net worth dipped by a decrease of 5.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shanbalaji Pharma?
In 2023, Shanbalaji Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indian Hospitex Private LimitedPalepu Gopal and Narasaiah Arigela are mutual person
Sri Balajhi Logistics Pharma LlpPalepu Gopal and Selvakumar Shanmugham are mutual person
- Pleasant Exports India Llp
Palepu Gopal is a mutual person
- Pleasant Foods Private Limited
Palepu Gopal is a mutual person
- Lph Pharma Private Limited
Palepu Gopal is a mutual person
- Shanbalaji Pharma Distributors Private Limited
Palepu Gopal and Selvakumar Shanmugham are mutual person
Charges (Loans)
₹0
₹90.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 9.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Nov 2018 | Hdfc Bank Limited | ₹9.00 Cr | Satisfied |
How Many Employees Work at Shanbalaji Pharma?
Shanbalaji Pharma has a workforce of 20 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shanbalaji Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shanbalaji Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
